Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
United Imaging To Feature Leaders of Choice Program, Innovative Purchasing Models, and World's-First Equipment at AHRA in Phoenix 2022-07-07 20:18
SunHo Announces First Patient Dosed in Phase 1/2 Clinical Trial of Two First-in-class Immunocytokines: IAP0971 and IAE0972 2022-07-07 20:00
Zhiyi Biotech Raised $45 Million in Series B Funding Round to Accelerate the Clinical Development of LBPs Pipelines 2022-07-07 17:45
WuXi STA Opens New Large-scale Oligonucleotide and Peptide Manufacturing Facility 2022-07-07 08:00
Alterity Therapeutics Doses First Patient in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy 2022-07-06 23:00
I-Mab to Host 2022 R&D Day 2022-07-06 20:00
US FDA AWARDS RARE PEDIATRIC DISEASE DESIGNATION (RPDD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCER 2022-07-06 19:00
Inmagene and HUTCHMED Announce First Participants in Global Phase I Trial of IMG-007 2022-07-06 12:00
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 2022-07-06 04:16
Winner Medical Acquires 100% Stake in Guilin Latex, Expanding into Medical Latex Market 2022-07-05 21:07
EditForce and Mitsubishi Tanabe Pharma Enter into License Agreement 2022-07-05 15:00
QunaSys co-hosts industry, government leaders for Pistoia Alliance Global Knowledge-Sharing virtual event 2022-07-05 10:00
ClinChoice Raises $150 mm Series E Round Financing, Further Strengthening its Global Services Capabilities 2022-07-05 09:20
Arctic Vision Announces First Patient Enrolled in Phase III Clinical Trial of ARVN003 for Presbyopia 2022-07-04 22:14
Abbisko Therapeutics Completed Dosing of First Patient for Its First-in-Class Highly Selective FGFR2/3 Inhibitor ABSK061 2022-07-04 13:34
ReviR Therapeutics Appoints Paul August, Ph.D., as Chief Scientific Officer 2022-07-01 22:00
Fosun's Businesses Shows Strong Recovery Momentum as Consumption Regains Vitality and Tourism Industry Continues to Recover 2022-06-30 20:16
Ascentage Pharma Announces IND Clearance by the US FDA for First-in-Human Study of Novel EED Inhibitor APG-5918 2022-06-30 10:41
Akeso's Cadonilimab (PD-1/CTLA-4), the First Dual Immune Checkpoint Inhibitor to Treat Cancer, Approved for Marketing in China 2022-06-29 20:14
Supporting Communities and Sharing Happiness, 28 Liberty Successfully Hosts Multiple Community Events at New York's Fosun Plaza 2022-06-29 09:00
1 121 122 123 124 125 432